{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:38:29Z","timestamp":1761824309662,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11060-021-03775-x","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T17:03:00Z","timestamp":1621270980000},"page":"351-360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effect of adjuvant radiotherapy after subtotal resection for WHO grade I meningioma: a propensity score matching analysis of the Brain Tumor Registry of Japan"],"prefix":"10.1007","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0842-5092","authenticated-orcid":false,"given":"Soichi","family":"Oya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusao","family":"Ikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Wanibuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukinori","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Nakatomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Mikuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"key":"3775_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00701-019-03799-3","volume":"161","author":"A Corell","year":"2019","unstructured":"Corell A, Thurin E, Skoglund T, Farahmand D, Henriksson R, Rydenhag B, Gulati S, Bartek J Jr, Jakola AS (2019) Neurosurgical treatment and outcome patterns of meningioma in Sweden: a nationwide registry-based study. Acta Neurochir 161:333\u2013341. https:\/\/doi.org\/10.1007\/s00701-019-03799-3","journal-title":"Acta Neurochir"},{"key":"3775_CR2","unstructured":"Lem\u00e9e JM, Corniola MV, Da Broi M, Schaller K, Meling TR. (2019). Early Postoperative Complications in Meningioma: Predictive Factors and Impact on Outcome. World Neurosurg 128, e851\u2013e858. https:\/\/urldefense.proofpoint.com\/v2\/url?u=http-3A__doi.org_10.1016_j.wneu.2019.05.010&d=DwIFaQ&c=vh6FgFnduejNhPPD0fl_yRaSfZy8CWbWnIf4XJhSqx8&r=r2aSgYn6PHMQXXmeBiKsnvfFG9T9U5fmdQ67xEVmgo0&m=05N_44vN1lB8GHNcXXUlHq5HG5Tn74yZIQSG-WJoX0o&s=llz8KBkUkAmD__eFAjSwArdhDnShpTqycWQpdCSff8&e="},{"key":"3775_CR3","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.oa.2020-0304","author":"S Oya","year":"2020","unstructured":"Oya S, Ikawa F, Ichihara N, Wanibuchi M, Akiyama Y, Nakatomi H, Mikuni N, Narita Y (2020) Nation-wide Brain Tumor Registry-based Study of Intracranial Meningioma in Japan: analysis of surgery-related risks. Neurol Med Chir (Tokyo). https:\/\/doi.org\/10.2176\/nmc.oa.2020-0304","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"3775_CR4","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.3171\/2018.1.FOCUS17730","volume":"44","author":"Kolakshyapati M, Ikawa F, Abiko M, Mitsuhara T, Kinoshita Y, Takeda M, Kurisu K, Alumni Association Group of the Department of Neurosurgery at Hiroshima University","year":"2018","unstructured":"Kolakshyapati M, Ikawa F, Abiko M, Mitsuhara T, Kinoshita Y, Takeda M, Kurisu K, Alumni Association Group of the Department of Neurosurgery at Hiroshima University (2018) Multivariate risk factor analysis and literature review of postoperative deterioration in Karnofsky Performance Scale score in elderly patients with skull base meningioma. Neurosurg Focus 44:E14. https:\/\/doi.org\/10.3171\/2018.1.FOCUS17730","journal-title":"Neurosurg Focus"},{"key":"3775_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2015.9.JNS15754","volume":"125","author":"K Gousias","year":"2016","unstructured":"Gousias K, Schramm J, Simon M (2016) The Simpson grading revisited: aggressive surgery and its place in modern meningioma management. J Neurosurg 125:1\u201310. https:\/\/doi.org\/10.3171\/2015.9.JNS15754","journal-title":"J Neurosurg"},{"key":"3775_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2016.1.JNS151842","volume":"126","author":"A Nanda","year":"2016","unstructured":"Nanda A, Bir SC, Maiti TK, Konar SK, Missios S, Guthikonda B (2016) Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma. J Neurosurg 126:1\u201311. https:\/\/doi.org\/10.3171\/2016.1.JNS151842","journal-title":"J Neurosurg"},{"key":"3775_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1227\/01.NEU.0000311061.72626.0D","volume":"62","author":"D Kondziolka","year":"2008","unstructured":"Kondziolka D, Mathieu D, Lunsford LD, Martin JJ, Madhok R, Niranjan A, Flickinger JC (2008) Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery 62:53\u201358; discussion 58\u201360. https:\/\/doi.org\/10.1227\/01.NEU.0000311061.72626.0D","journal-title":"Neurosurgery"},{"key":"3775_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","volume":"122","author":"L Rogers","year":"2015","unstructured":"Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J, Schiff D, Weber DC, Wen PY, Vogelbaum MA (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 122:4\u201323. https:\/\/doi.org\/10.3171\/2014.7.JNS131644","journal-title":"J Neurosurg"},{"key":"3775_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1227\/NEU.0b013e31822d408a","volume":"70","author":"A Santacroce","year":"2012","unstructured":"Santacroce A, Walier M, R\u00e9gis J et al (2012) Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery 70:32\u201339; discussion 39. https:\/\/doi.org\/10.1227\/NEU.0b013e31822d408a","journal-title":"Neurosurgery"},{"key":"3775_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/s0360-3016(97)00317-9","volume":"39","author":"KS Condra","year":"1997","unstructured":"Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr, Rhoton AL (1997) Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 39:427\u2013436. https:\/\/doi.org\/10.1016\/s0360-3016(97)00317-9","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3775_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.radonc.2004.01.006","volume":"71","author":"S Soyuer","year":"2004","unstructured":"Soyuer S, Chang EL, Selek U, Shi W, Maor MH, DeMonte F (2004) Radiotherapy after surgery for benign cerebral meningioma. Radiother Oncol 71:85\u201390. https:\/\/doi.org\/10.1016\/j.radonc.2004.01.006","journal-title":"Radiother Oncol"},{"key":"3775_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/s0360-3016(98)90008-6","volume":"15","author":"BW Taylor","year":"1988","unstructured":"Taylor BW, Marcus RB, Friedman WA, Ballinger WE Jr, Million RR (1988) The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 15:299\u2013304. https:\/\/doi.org\/10.1016\/s0360-3016(98)90008-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3775_CR13","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.ijrobp.2019.11.028","volume":"106","author":"CL Rogers","year":"2020","unstructured":"Rogers CL, Won M, Vogelbaum MA et al (2020) High-risk meningioma: initial outcomes from NRG Oncology\/RTOG 0539. Int J Radiat Oncol Biol Phys 106:790\u2013799. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.11.028","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3775_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3171\/2016.11.JNS161170","volume":"129","author":"L Rogers","year":"2018","unstructured":"Rogers L, Zhang P, Vogelbaum MA et al (2018) Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539. J Neurosurg 129:35\u201347. https:\/\/doi.org\/10.3171\/2016.11.JNS161170","journal-title":"J Neurosurg"},{"key":"3775_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.radonc.2018.06.018","volume":"128","author":"DC Weber","year":"2018","unstructured":"Weber DC, Ares C, Villa S et al (2018) Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a phase-II parallel non-randomized and observation study (EORTC 22042\u201326042). Radiother Oncol 128:260\u2013265. https:\/\/doi.org\/10.1016\/j.radonc.2018.06.018","journal-title":"Radiother Oncol"},{"key":"3775_CR16","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015. Neuro Oncol 20:iv1\u2013iv86. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro Oncol"},{"key":"3775_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/neuonc\/nov247","volume":"18","author":"CL Rogers","year":"2016","unstructured":"Rogers CL, Perry A, Pugh S et al (2016) Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro Oncol 18:565\u2013574. https:\/\/doi.org\/10.1093\/neuonc\/nov247","journal-title":"Neuro Oncol"},{"key":"3775_CR18","doi-asserted-by":"publisher","first-page":"e567","DOI":"10.7759\/cureus.567","volume":"8","author":"M Amsbaugh","year":"2016","unstructured":"Amsbaugh M, Ugiliweneza B, Burton E, Skirboll S, Woo S, Boakye M (2016) Patterns of care and outcomes of adjuvant radiotherapy for meningiomas: a Surveillance, Epidemiology, and End Results and Medicare Linked Analysis. Cureus 8:e567. https:\/\/doi.org\/10.7759\/cureus.567","journal-title":"Cureus"},{"key":"3775_CR19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/02688697.2019.1661965","volume":"33","author":"AR Brodbelt","year":"2019","unstructured":"Brodbelt AR, Barclay ME, Greenberg D, Williams M, Jenkinson MD, Karabatsou K (2019) The outcome of patients with surgically treated meningioma in England: 1999\u20132013. A cancer registry data analysis. Br J Neurosurg 33:641\u2013647. https:\/\/doi.org\/10.1080\/02688697.2019.1661965","journal-title":"Br J Neurosurg"},{"key":"3775_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3171\/2011.3.JNS101748","volume":"115","author":"KS Cahill","year":"2011","unstructured":"Cahill KS, Claus EB (2011) Treatment and survival of patients with nonmalignant intracranial meningioma: results from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. Clinical article. J Neurosurg 115:259\u2013267. https:\/\/doi.org\/10.3171\/2011.3.JNS101748","journal-title":"J Neurosurg"},{"key":"3775_CR21","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/2019.3.FOCUS1971","volume":"46","author":"AK Reddy","year":"2019","unstructured":"Reddy AK, Ryoo JS, Denyer S, McGuire LS, Mehta AI (2019) Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis. Neurosurg Focus 46:E3. https:\/\/doi.org\/10.3171\/2019.3.FOCUS1971","journal-title":"Neurosurg Focus"},{"key":"3775_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.clon.2013.10.001","volume":"26","author":"J Maclean","year":"2014","unstructured":"Maclean J, Fersht N, Short S (2014) Controversies in radiotherapy for meningioma. Clin Oncol (R Coll Radiol) 26:51\u201364. https:\/\/doi.org\/10.1016\/j.clon.2013.10.001","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"3775_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2176\/nmc.sup.2017-0001","volume":"57","author":"Committee of Brain Tumor Registry of Japan Supported by the Japan Neurosurgical Society","year":"2017","unstructured":"Committee of Brain Tumor Registry of Japan Supported by the Japan Neurosurgical Society (2017) Brain Tumor Registry of Japan (2005\u20132008). Neurol Med Chir (Tokyo) 57:9\u2013102. https:\/\/doi.org\/10.2176\/nmc.sup.2017-0001","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"3775_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2176\/nmc.sup.2014-0000","volume":"54","author":"Committee of Brain Tumor Registry of Japan Supported by the Japan Neurosurgical Society","year":"2014","unstructured":"Committee of Brain Tumor Registry of Japan Supported by the Japan Neurosurgical Society (2014) Brain Tumor Registry of Japan (2001\u20132004). Neurol Med Chir (Tokyo) 54:1\u2013102","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"3775_CR25","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3171\/2010.11.JNS10701","volume":"114","author":"S Ohba","year":"2011","unstructured":"Ohba S, Kobayashi M, Horiguchi T, Onozuka S, Yoshida K, Ohira T, Kawase T (2011) Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas. J Neurosurg 114:1278\u20131287. https:\/\/doi.org\/10.3171\/2010.11.JNS10701","journal-title":"J Neurosurg"},{"key":"3775_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1227\/00006123-198704000-00003","volume":"20","author":"NM Barbaro","year":"1987","unstructured":"Barbaro NM, Gutin PH, Wilson CB, Sheline GE, Boldrey EB, Wara WM (1987) Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 20:525\u2013528. https:\/\/doi.org\/10.1227\/00006123-198704000-00003","journal-title":"Neurosurgery"},{"key":"3775_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF00172765","volume":"13","author":"Miralbell R, Linggood RM, la Monte de S, Convery K, Munzenrider JE, Mirimanoff RO","year":"1992","unstructured":"Miralbell R, Linggood RM, la Monte de S, Convery K, Munzenrider JE, Mirimanoff RO (1992) The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol 13:157\u2013164. https:\/\/doi.org\/10.1007\/BF00172765","journal-title":"J Neurooncol"},{"key":"3775_CR28","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","volume":"17","author":"R Goldbrunner","year":"2016","unstructured":"Goldbrunner R, Minniti G, Preusser M et al (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17:e383\u2013e391. https:\/\/doi.org\/10.1016\/S1470-2045(16)30321-7","journal-title":"Lancet Oncol"},{"key":"3775_CR29","unstructured":"National Comprehensive Cancer Network. NCCN: NCCN guidelines: Central Nervous System Cancers. NCCN.org (http:\/\/www.nccn.org\/). Accessed 31 Mar 2021."},{"key":"3775_CR30","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/2015.1.FOCUS14757","volume":"38","author":"SQ Sun","year":"2015","unstructured":"Sun SQ, Hawasli AH, Huang J et al (2015) An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas. Neurosurg Focus 38:E3. https:\/\/doi.org\/10.3171\/2015.1.FOCUS14757","journal-title":"Neurosurg Focus"},{"key":"3775_CR31","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00701-014-2156-z","volume":"156","author":"S Hammouche","year":"2014","unstructured":"Hammouche S, Clark S, Wong AHL, Chicoine MR, Kim AH (2014) Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment. Acta Neurochir 156:1475\u20131481. https:\/\/doi.org\/10.1007\/s00701-014-2156-z","journal-title":"Acta Neurochir"},{"key":"3775_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jocn.2015.09.021","volume":"28","author":"MD Jenkinson","year":"2016","unstructured":"Jenkinson MD, Waqar M, Farah JO et al (2016) Early adjuvant radiotherapy in the treatment of atypical meningioma. J Clin Neurosci 28:87\u201392. https:\/\/doi.org\/10.1016\/j.jocn.2015.09.021","journal-title":"J Clin Neurosci"},{"key":"3775_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1227\/NEU.0000000000000461","volume":"75","author":"SQ Sun","year":"2014","unstructured":"Sun SQ, Kim AH, Cai C et al (2014) Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection. Neurosurgery 75:347\u2013354; discussion 354\u2013355; quiz 355. https:\/\/doi.org\/10.1227\/NEU.0000000000000461","journal-title":"Neurosurgery"},{"key":"3775_CR34","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/neuonc\/nou098","volume":"16","author":"AA Aizer","year":"2014","unstructured":"Aizer AA, Arvold ND, Catalano P et al (2014) Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro-Oncolgoy 16:1547\u20131553. https:\/\/doi.org\/10.1093\/neuonc\/nou098","journal-title":"Neuro-Oncolgoy"},{"key":"3775_CR35","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3171\/2016.5.JNS152809","volume":"126","author":"HP Bagshaw","year":"2017","unstructured":"Bagshaw HP, Burt LM, Jensen RL, Suneja G, Palmer CA, Couldwell WT, Shrieve DC (2017) Adjuvant radiotherapy for atypical meningiomas. J Neurosurg 126:1822\u20131828. https:\/\/doi.org\/10.3171\/2016.5.JNS152809","journal-title":"J Neurosurg"},{"key":"3775_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11060-009-9934-0","volume":"95","author":"A Durand","year":"2009","unstructured":"Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamarid\u00e8s M, Menei P, Deruty R, Moreau JJ, F\u00e8vreMontange M, Guyotat J (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95:367\u2013375. https:\/\/doi.org\/10.1007\/s11060-009-9934-0","journal-title":"J Neurooncol"},{"key":"3775_CR37","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13014-019-1368-z","volume":"14","author":"SM Hemmati","year":"2019","unstructured":"Hemmati SM, Ghadjar P, Gr\u00fcn A, Badakhshi H, Zschaeck S, Senger C, Acker G, Misch M, Budach V, Kaul D (2019) Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma. Radiat Oncol 14:160\u2013167. https:\/\/doi.org\/10.1186\/s13014-019-1368-z","journal-title":"Radiat Oncol"},{"key":"3775_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11060-020-03604-7","volume":"149","author":"DA Brown","year":"2020","unstructured":"Brown DA, Goyal A, Kerezoudis P et al (2020) Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry. J Neurooncol 149:293\u2013303. https:\/\/doi.org\/10.1007\/s11060-020-03604-7","journal-title":"J Neurooncol"},{"key":"3775_CR39","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/neuonc\/nox007","volume":"19","author":"C Wang","year":"2017","unstructured":"Wang C, Kaprealian TB, Suh JH, Kubicky CD, Ciporen JN, Chen Y, Jaboin JJ (2017) Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma. Neuro Oncol 19:1263\u20131270. https:\/\/doi.org\/10.1093\/neuonc\/nox007","journal-title":"Neuro Oncol"},{"key":"3775_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10143-020-01428-7","volume":"32","author":"F Behling","year":"2020","unstructured":"Behling F, Fodi C, Hoffmann E et al (2020) The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy. Neurosurg Rev 32:1\u20138. https:\/\/doi.org\/10.1007\/s10143-020-01428-7","journal-title":"Neurosurg Rev"},{"key":"3775_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2018.6.JNS18118","volume":"131","author":"ST Magill","year":"2018","unstructured":"Magill ST, Dalle Ore CL, Diaz MA, Jalili DD, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW (2018) Surgical outcomes after reoperation for recurrent non-skull base meningiomas. J Neurosurg 131:1\u20139. https:\/\/doi.org\/10.3171\/2018.6.JNS18118","journal-title":"J Neurosurg"},{"key":"3775_CR42","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3171\/2017.11.JNS172278","volume":"130","author":"ST Magill","year":"2018","unstructured":"Magill ST, Lee DS, Yen AJ, Lucas CG, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW (2018) Surgical outcomes after reoperation for recurrent skull base meningiomas. J Neurosurg 130:876\u2013883. https:\/\/doi.org\/10.3171\/2017.11.JNS172278","journal-title":"J Neurosurg"},{"key":"3775_CR43","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s00432-019-02891-6","volume":"145","author":"S Park","year":"2019","unstructured":"Park S, Cha YJ, Suh SH, Lee IJ, Lee KS, Hong CK, Kim JW (2019) Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma. J Cancer Res Clin Oncol 145:1351\u20131360. https:\/\/doi.org\/10.1007\/s00432-019-02891-6","journal-title":"J Cancer Res Clin Oncol"},{"key":"3775_CR44","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3171\/2012.11.JNS112011","volume":"119","author":"F Tomasello","year":"2013","unstructured":"Tomasello F, Conti A, Cardali S, Angileri FF (2013) Venous preservation\u2013guided resection: a changing paradigm in parasagittal meningioma surgery. J Neurosurg 119:74\u201381. https:\/\/doi.org\/10.3171\/2012.11.JNS112011","journal-title":"J Neurosurg"},{"key":"3775_CR45","doi-asserted-by":"publisher","first-page":"e1015","DOI":"10.1016\/j.wneu.2019.07.068","volume":"130","author":"A Gomes Dos Santos","year":"2019","unstructured":"Gomes Dos Santos A, Solla DJF, Moscardi R, Neville IS, Weltman E, Teixeira MJ, Paiva WS (2019) Adjuvant radiotherapy did not reduce recurrence of World Health Organization Grade I meningiomas with venous sinus involvement: a propensity score adjusted analysis and literature review. World Neurosurg 130:e1015\u2013e1019. https:\/\/doi.org\/10.1016\/j.wneu.2019.07.068","journal-title":"World Neurosurg"},{"key":"3775_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-021-04766-7","author":"P Lv","year":"2021","unstructured":"Lv P, Wang JJ, Xiong NX, Liu XM, Yao DX, Jiang XB, Zhao HY, Zhang FC, Fu P (2021) Long-term outcome in meningiomas involving the major dural sinuses with combined therapy of subtotal resection and early postoperative gamma knife radiosurgery. Acta Neurochir. https:\/\/doi.org\/10.1007\/s00701-021-04766-7","journal-title":"Acta Neurochir"},{"key":"3775_CR47","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng.2526","volume":"45","author":"PK Brastianos","year":"2013","unstructured":"Brastianos PK, Horowitz PM, Santagata S et al (2013) Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet 45:285\u2013289. https:\/\/doi.org\/10.1038\/ng.2526","journal-title":"Nat Genet"},{"key":"3775_CR48","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339:1077\u20131080. https:\/\/doi.org\/10.1126\/science.1233009","journal-title":"Science"},{"key":"3775_CR49","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3171\/2011.11.JNS11999","volume":"116","author":"N Hashimoto","year":"2012","unstructured":"Hashimoto N, Rabo CS, Okita Y et al (2012) Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies. J Neurosurg 116:574\u2013580. https:\/\/doi.org\/10.3171\/2011.11.JNS11999","journal-title":"J Neurosurg"},{"key":"3775_CR50","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2176\/nmc.oa.2016-0172","volume":"56","author":"K Yoshimoto","year":"2016","unstructured":"Yoshimoto K, Kada A, Kuga D et al (2016) Current trends and healthcare resource usage in the Hospital Treatment of Primary Malignant Brain Tumor in Japan: a National Survey Using the Diagnostic Procedure Combination Database (J-ASPECT Study-Brain Tumor). Neurol Med Chir (Tokyo) 56:664\u2013673. https:\/\/doi.org\/10.2176\/nmc.oa.2016-0172","journal-title":"Neurol Med Chir (Tokyo)"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03775-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-021-03775-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03775-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T18:11:57Z","timestamp":1623953517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-021-03775-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["3775"],"URL":"https:\/\/doi.org\/10.1007\/s11060-021-03775-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2021,5,17]]},"assertion":[{"value":"2 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The requirement for written consent from patients was waived by the ethical review boards because of the retrospective nature of the study design and use of anonymized data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have approved the manuscript and agree with publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}